Jacobs Levy Equity Management, Inc Precision Biosciences Inc Transaction History

Jacobs Levy Equity Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	BUY	$0.34 - $0.69 $218,905 - $444,248	643,839 Added 82.47%	1,424,535 $484,000
Q2 2023 Aug 14, 2023	SELL	$0.52 - $0.91 $3,227 - $5,648	-6,207 Reduced 0.79%	780,696 $413,000
Q1 2023 May 15, 2023	BUY	$0.7 - $1.41 $550,832 - $1.11 Million	786,903 New	786,903 $590,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $91,922 - $144,840	-12,422 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $613,569 - $1.13 Million	-71,595 Reduced 85.21%	12,422 $129,000
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $371,609 - $774,910	-62,142 Reduced 42.52%	84,017 $701,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $71,912 - $135,009	15,465 Added 11.83%	146,159 $900,000
Q2 2020 Aug 17, 2020	BUY	$4.66 - $8.7 $498,703 - $931,056	107,018 Added 452.01%	130,694 $1.09 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $15.01 $119,563 - $355,376	23,676 New	23,676 $143,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $521M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.